0000950170-23-050434.txt : 20230928 0000950170-23-050434.hdr.sgml : 20230928 20230928160504 ACCESSION NUMBER: 0000950170-23-050434 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaMond Stephen J CENTRAL INDEX KEY: 0001951073 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39951 FILM NUMBER: 231289496 MAIL ADDRESS: STREET 1: 3350 W BAYSHORE ROAD STREET 2: SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Peak Bio, Inc. CENTRAL INDEX KEY: 0001834645 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 852448157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4900 HOPYARD ROAD, SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 463-4800 MAIL ADDRESS: STREET 1: 4900 HOPYARD ROAD, SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: Ignyte Acquisition Corp. DATE OF NAME CHANGE: 20201202 4/A 1 ownership.xml 4/A X0508 4/A 2023-09-15 2023-09-19 0001834645 Peak Bio, Inc. PKBO 0001951073 LaMond Stephen J 4900 HOPYARD ROAD SUITE 100 PLEASANTON CA 94588 true true false false See Remarks false Common Stock 2023-09-15 4 P false 11750 A 11750 D Common Stock 2023-09-18 4 P false 2500 A 14250 D Dr. LaMond previously reported purchases of 26,000 shares of the Company's Common Stock on September 15, 2023 in error. Instead, on September 15, 2023, Dr. Stephen LaMond purchased a total of 11,750 shares of the Company's Common Stock at prices ranging from $0.27 per share to $0.43 per share. On September 18, 2023, Dr. Stephen LaMond purchased a total of 2,500 shares of the Company's Common Stock at prices ranging from $0.23 per share to $0.29 per share. Interim Chief Executive Officer /s/ Dr. Stephen LaMond 2023-09-28